Talis Biomedical Corporation

TLIS · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$76,732$130,191$232,545$138,483
Short-Term Investments$0$0$0$0
Receivables$50$308$183$471
Inventory$0$0$0$0
Other Curr. Assets$901$2,783$3,387$49,770
Total Curr. Assets$77,683$133,282$236,115$188,724
Property Plant & Equip (Net)$15,449$34,232$23,435$9,681
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$1,542$1,776$767$0
Tax Assets$3,666$7,469$0$0
Other NC Assets$1,542$1,776$5,511$0
Total NC Assets$20,657$36,008$29,713$9,681
Other Assets-$3,666$0$0$0
Total Assets$94,674$169,290$265,828$198,405
Liabilities
Payables$1,339$3,768$5,122$4,906
Short-Term Debt$2,882$3,703$2,464$1,386
Tax Payable$0$0$0$0
Deferred Revenue$0$0$11,672$9,706
Other Curr. Liab.$4,551$5,201-$152$28
Total Curr. Liab.$8,772$12,672$19,106$16,026
LT Debt$16,786$29,879$12,745$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$290,950
Total NC Liab.$16,786$29,879$12,745$290,950
Other Liabilities$0$0$0$0
Cap. Leases$19,668$33,582$13,977$693
Total Liabilities$25,558$42,551$31,851$306,976
Equity
Pref Stock$3$0$3$0
Common Stock$0$3$3$0
Retained Earnings-$539,961-$477,954-$364,942-$172,906
AOCI$0$0$0$0
Other Equity$609,074$604,687$598,913-$226,610
Total Equity$69,116$126,739$233,977-$108,571
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$94,674$169,290$265,828$198,405
Net Debt-$57,064-$96,609-$217,336-$137,097